Peptide Graded

Dalbavancin / Oritavancin / Telavancin

Is Dalbavancin / Oritavancin / Telavancin legal in the US?

Yes, FDA approved for skin infections caused by certain bacteria.

AStrong human evidenceFDA approvedas of 2026-10-26

All three lipoglycopeptides are FDA-approved for skin and skin-structure infections caused by susceptible Gram-positive bacteria: telavancin as Vibativ for complicated skin and skin-structure infections (2009, with hospital-acquired and ventilator-associated pneumonia due to S. aureus added in 2013 when alternatives are unsuitable), dalbavancin as Dalvance (2014, extended to children in 2021) and oritavancin as Orbactiv (2014) and Kimyrsa (2021), both for acute bacterial skin and skin-structure infections. 423

Yes. Telavancin (Vibativ) has been approved since 2009. Dalbavancin (Dalvance) and oritavancin (Orbactiv) have been approved since 2014. A second oritavancin product (Kimyrsa) followed in 2021. All are approved for skin infections. Those are acute bacterial infections for dalbavancin and oritavancin, and complicated ones for telavancin. Telavancin is also approved for certain hospital pneumonias. 423

Read the full Dalbavancin / Oritavancin / Telavancin page

More on Dalbavancin / Oritavancin / Telavancin

Citations

  1. Boucher 2014, NEJM: once-weekly dalbavancin versus daily conventional therapy for skin infection (DISCOVER 1 and 2) doi.org
  2. Dalvance (dalbavancin) prescribing information drugs.com
  3. Orbactiv (oritavancin) prescribing information drugs.com
  4. Vibativ (telavancin) prescribing information drugs.com

Reference information only, not medical advice. Drawn from the Dalbavancin / Oritavancin / Telavancin article, fact-checked against the cited sources. No dosing anywhere on this site.